New ANDA Cases

Winter 2014

GENERICally Speaking
Case Name Date Filed Judge Drug Patent No(s).
Shire LLC v. Amerigan Pharms. Ltd., 14-6095 (D.N.J.) Oct. 1, 2014 Hon. Renee Marie Bumb Adderall XR® (dextroamphetamine sulfate / dextroamphetamine saccharate /
amphetamine aspartate monohydrate / amphetamine sulfate tablets)
RE42,096
RE41,148
Supernus Pharms., Inc. v. Actavis, Inc., 14-6102 (D.N.J.) Oct. 1, 2014 Hon. Susan D. Wigenton Trokendi XR® (topiramate extended-release capsules) 8,298,576
8,298,580
8,663,683
Kowa Co., Ltd. v. Apotex, Inc., 14-7934 (S.D.N.Y.) Oct. 1, 2014 Hon. Paul A. Crotty Livalo® (pitavastatin calcium tablets) 8,557,993
Sandoz Inc. v. EKR Therapeutics, LLC, IPR2015-00005 (PTAB) Oct. 1, 2014 N/A Cardene® (nicardipine hydrochloride) 8,455,524
Sandoz Inc. v. EKR Therapeutics, LLC, IPR2015-00006 (PTAB) Oct. 1, 2014 N/A Cardene® (nicardipine hydrochloride) 7,612,102
Sandoz Inc. v. EKR Therapeutics, LLC, IPR2015-00007 (PTAB) Oct. 1, 2014 N/A Cardene® (nicardipine hydrochloride) 7,659,290
Sandoz Inc. v. EKR Therapeutics, LLC, IPR2015-00008 (PTAB) Oct. 1, 2014 N/A Cardene® (nicardipine hydrochloride) 7,659,291
Kowa Co., Ltd. v. Apotex, Inc., 14-1264 (D. Del.) Oct. 2, 2014 Hon. Sue L. Robinson Livalo® (pitavastatin calcium tablets) 8,557,993
Forest Labs., LLC v. Hikma Pharms., LLC, 14-1266 (D. Del.) Oct. 2, 2014 Hon. Sue L. Robinson Saphris® (asenapine maleate tablets) 8,022,228
7,741,358
Jazz Pharms., Inc. v. Par Pharm., Inc., 14-6150 (D.N.J.) Oct. 2, 2014 Hon. Esther Salas Xyrem® (sodium oxybate oral solution) 8,772,306
Jazz Pharms., Inc. v. Ranbaxy Labs., Ltd., 14-6151 (D.N.J.) Oct. 2, 2014 Hon. Esther Salas Xyrem® (sodium oxybate oral solution) 8,772,306
Otsuka Pharm. Co., Ltd. v. Intas Pharms. Ltd., 14-6158 (D.N.J.) Oct. 2, 2014 Hon. Jerome B. Simandle Abilify® (aripiprazole tablets) 8,759,350
Forest Labs, LLC v. Amerigan Pharms., Inc., 14-1271 (D. Del.) Oct. 3, 2014 Hon. Leonard P. Stark Namenda XR® (memantine hydrochloride
extended-release capsules)
8,039,009
8,168,209
8,173,708
8,283,379
8,329,752
8,362,085
8,598,233
Teva Pharms. USA, Inc. v. Mylan Pharms. Inc., 14-1278 (D. Del.) Oct. 6, 2014 Hon. Gregory M. Sleet Copaxone® (glatiramer acetate for injection) 8,232,250
8,399,413
Otsuka Pharm. Co., Ltd. v. Sun Pharm. Industries Ltd., 14-6397 (D.N.J.) Oct. 6, 2014 Hon. Jerome B. Simandle Abilify® (aripiprazole tablets) 8,759,350
Teva Pharms. USA, Inc. v. Mylan Pharms. Inc., 14-0167 (N.D.W.V.) Oct. 7, 2014 Hon. Irene M. Keeley Copaxone® (glatiramer acetate for injection) 8,232,250
8,399,413
Novartis Pharms. Corp. v. Dr. Reddy’s Labs., Ltd., 14-1283 (D. Del.) Oct. 8, 2014 Hon. Leonard P. Stark Gleevec® (imatinib mesylate capsules) 6,894,051
RE43,932
Eli Lilly and Co. v. Nang Kuang Pharm. Co., Ltd., 14-1647 (S.D. Ind.) Oct. 8, 2014 Hon. Jane Magnus-Stinson Alimta® (pemetrexed disodium for intravenous infusion) 5,344,932
7,772,209
AbbVie Inc. v. Mylan Pharms. Inc., 14-1288 (D. Del.) Oct. 9, 2014 Hon. Richard G. Andrews Norvir® (ritonavir tablets) 7,148,359
7,364,752
Novartis Pharms. Corp. v. Dr. Reddy’s Labs., Ltd., 14-6280 (D.N.J.) Oct. 9, 2014 Hon. Claire C. Cecchi Gleevec® (imatinib mesylate capsules) 6,894,051
RE43,932
Braintree Labs., Inc. v. Taro Pharms. USA, Inc., 14-8147 (S.D.N.Y.) Oct. 9, 2014 Hon. Alison J. Nathan Suprep® (sodium sulfate, potassium sulfate, magnesium sulfate oral solution) 6,946,149
Novartis Pharms. Corp. v. Par Pharm., Inc., 14-1289 (D. Del.) Oct. 10, 2014 Hon. Richard G. Andrews Zortress® (everolimus tablets) 5,665,772
6,004,973
6,455,518
Otsuka Pharm. Co., Ltd. v. Amneal Pharms., LLC, 14-6340 (D.N.J.) Oct. 10, 2014 Hon. Mary L. Cooper Abilify® (aripiprazole oral solution) 8,759,350
Otsuka Pharm. Co., Ltd. v. Teva Pharms. USA, Inc., 14-6398 (D.N.J.) Oct. 10, 2014 Hon. Jerome B. Simandle Abilify® (aripiprazole tablets) 8,580,796
8,642,760
Helsinn Healthcare S.A. v. Teva Pharms. USA, Inc., 14-6341 (D.N.J.) Oct. 13, 2014 Hon. Mary L. Cooper Aloxi® (palonosetron hydrochloride IV solutions) 8,729,094
Tris Pharma, Inc. v. Actavis Labs. FL, Inc., 14-1309 (D. Del.) Oct. 15, 2014 Hon. Gregory M. Sleet Quillivant XR® (methylphenidate hydrochloride extended-release oral suspension) 8,465,765
8,563,033
8,778,390
Noven Therapeutics, LLC v. Actavis Labs. FL, Inc., 14-6414 (D.N.J.) Oct. 16, 2014 Hon. Faith S. Hochberg Brisdelle® (paroxetine mesylate capsule) 5,874,447
7,598,271
8,658,663
Tris Pharma, Inc. v. Actavis Labs. FL, Inc., 14-6425 (D.N.J.) Oct. 16, 2014 Hon. Stanley R. Chesler Quillivant XR® (methylphenidate hydrochloride extended-release oral suspension) 8,465,765
8,563,033
8,778,390
Cephalon, Inc. v. Wockhardt Bio Ltd., 14-1332 (D. Del.) Oct. 21, 2014 Hon. Gregory M. Sleet Treanda® (bendamustine hydrochloride for infusion) 8,445,524
8,436,190
8,609,863
8,791,270
AstraZeneca Pharms. LP v. Pharmadax USA, Inc., 14-6557 (D.N.J.) Oct. 22, 2014 Hon. Noel L. Hillman Seroquel® XR (quetiapine fumarate extended-release tablets) 5,948,437
AstraZeneca Pharms. LP v. Pharmadax USA, Inc., 14-1710 (C.D. Cal.) Oct. 23, 2014 Hon. James V. Selna Seroquel® XR (quetiapine fumarate extended-release tablets) 5,948,437
Agila Specialties Inc. v. Cubist Pharms., Inc., IPR2015-00131 (PTAB) Oct. 23, 2014 N/A Cubicin® (daptomycin for injection) 6,468,967
Agila Specialties Inc. v. Cubist Pharms., Inc., IPR2015-00132 (PTAB) Oct. 23, 2014 N/A Cubicin® (daptomycin for injection) 6,852,689
Agila Specialties Inc. v. Cubist Pharms., Inc., IPR2015-00140 (PTAB) Oct. 23, 2014 N/A Cubicin® (daptomycin for injection) 8,129,342
Agila Specialties Inc. v. Cubist Pharms., Inc., IPR2015-00141 (PTAB) Oct. 23, 2014 N/A Cubicin® (daptomycin for injection) 8,058,238
Agila Specialties Inc. v. Cubist Pharms., Inc., IPR2015-00142 (PTAB) Oct. 23, 2014 N/A Cubicin® (daptomycin for injection) 8,058,238
Agila Specialties Inc. v. Cubist Pharms., Inc., IPR2015-00143 (PTAB) Oct. 23, 2014 N/A Cubicin® (daptomycin for injection) 8,058,238
Agila Specialties Inc. v. Cubist Pharms., Inc., IPR2015-00144 (PTAB) Oct. 24, 2014 N/A Cubicin® (daptomycin for injection) 8,058,238
Otsuka Pharm. Co., Ltd. v. Apotex Corp., 14-6707 (D.N.J.) Oct. 27, 2014 Hon. Mary L. Cooper Abilify® (aripiprazole oral solution) 7,053,092
8,642,600
8,759,350
AstraZeneca AB v. Actavis Labs. FL, Inc., 14-1356 (D. Del.) Oct. 31, 2014 Hon. Gregory M. Sleet Kombiglyze® XR (saxagliptin hydrochloride / metformin hydrochloride tablets) RE44,186
8,628,799
Otsuka Pharm. Co., Ltd. v. Aurobindo Pharma Ltd., 14-6890 (D.N.J.) Oct. 31, 2014 Hon. Jerome B. Simandle Abilify® (aripiprazole tablets) 8,759,350
Daravita Ltd. v. Alvogen Pine Brook, Inc., 14-1364 (D. Del.) Nov. 3, 2014 Hon. Gregory M. Sleet Zohydro ER® (hydrocodone bitartrate extended-release capsules) 6,228,398
6,902,742
Senju Pharm. Co., Ltd. v. Innopharma Licensing, Inc., 14-6893 (D.N.J.) Nov. 3, 2014 Hon. Jerome B. Simandle Prolensa® (bromfenac ophthalmic solution) 8,129,431
8,669,290
8,754,131
8,871,813
Otsuka Pharm. Co., Ltd. v. Lupin Ltd., 14-7105 (D.N.J.) Nov. 3, 2014 Hon. Jerome B. Simandle Abilify® (aripiprazole tablets) 8,017,615
8,580,796
8,642,760
8,759,350
Fresenius-Kabi USA LLC v. Cubist Pharms., Inc., IPR2015-00223 (PTAB) Nov. 3, 2014 N/A Cubicin® (daptomycin for injection) 6,852,689
Fresenius-Kabi USA LLC v. Cubist Pharms., Inc., IPR2015-00227 (PTAB) Nov. 3, 2014 N/A Cubicin® (daptomycin for injection) 6,468,967
Teijin Ltd. v. Unimark Remedies, Ltd., 14-1370 (D. Del.) Nov. 4, 2014 Hon. Sue L. Robinson Uloric® (febuxostat tablets) 7,361,676
Endo Pharms. Inc. v. Actavis Inc., 14-1381 (D. Del.) Nov. 7, 2014 Hon. Richard G. Andrews Opana ER® (oxymorphone hydrochloride extended-release tablets) 8,808,737
8,871,779
Endo Pharms. Inc. v. Amneal Pharms., LLC, 14-1382 (D. Del.) Nov. 7, 2014 Hon. Richard G. Andrews Opana ER® (oxymorphone hydrochloride extended-release tablets) 8,808,737
8,871,779
Endo Pharms. Inc. v. Impax Labs., Inc., 14-1383 (D. Del.) Nov. 7, 2014 Hon. Richard G. Andrews Opana ER® (oxymorphone hydrochloride extended-release tablets) 8,808,737
8,871,779
Endo Pharms. Inc. v. Impax Labs., Inc., 14-1384 (D. Del.) Nov. 7, 2014 Hon. Richard G. Andrews Opana ER® (oxymorphone hydrochloride extended-release tablets) 8,808,737
8,871,779
Endo Pharms. Inc. v. Par Pharm. Companies, Inc., 14-1385 (D. Del.) Nov. 7, 2014 Hon. Richard G. Andrews Opana ER® (oxymorphone hydrochloride extended-release tablets) 8,808,737
8,871,779
Endo Pharms. Inc. v. Ranbaxy Labs. Ltd., 14-1386 (D. Del.) Nov. 7, 2014 Hon. Richard G. Andrews Opana ER® (oxymorphone hydrochloride extended-release tablets) 8,808,737
8,871,779
Endo Pharms. Inc. v. Roxane Labs., Inc., 14-1387 (D. Del.) Nov. 7, 2014 Hon. Richard G. Andrews Opana ER® (oxymorphone hydrochloride extended-release tablets) 8,808,737
8,871,779
Endo Pharms. Inc. v. Sandoz, Inc., 14-1388 (D. Del.) Nov. 7, 2014 Hon. Richard G. Andrews Opana ER® (oxymorphone hydrochloride extended-release tablets) 8,808,737
8,871,779
Endo Pharms. Inc. v. Teva Pharms. USA, Inc., 14-1389 (D. Del.) Nov. 7, 2014 Hon. Richard G. Andrews Opana ER® (oxymorphone hydrochloride extended-release tablets) 8,808,737
8,871,779
AstraZeneca Pharms. LP v. Pharmadax USA, Inc., 14-7007 (D.N.J.) Nov. 7, 2014 Hon. Noel L. Hillman Seroquel® XR (quetiapine fumarate extended-release tablets) 5,948,437
Shire Development Natco Pharma Ltd., 14-7053 (D.N.J.) Nov. 10, 2014 Hon. Stanley R. Chesler Fosrenol® (lanthanum carbonate chewable tablets) 5,968,976
7,381,428
7,465,465
Otsuka Pharm. Co., Ltd. v. Actavis Elizabeth LLC, 14-7106 (D.N.J.) Nov. 10, 2014 Hon. Jerome B. Simandle Abilify® (aripiprazole tablets) 8,580,796
8,642,760
8,759,350
Pfizer Inc. v. Tiger Pharms., LLC, 14-1501 (E.D. Va.) Nov. 10, 2014 Hon. Anthony J. Trenga Tikosyn® (dofetilide capsules) 6,124,363
Pfizer Inc. v. Tiger Pharms., LLC, 14-8958 (S.D.N.Y.) Nov. 10, 2014 Hon. Gregory H. Woods Tikosyn® (dofetilide capsules) 6,124,363
Baxter Healthcare Corp. v. Agila Specialties Private Ltd., 14-7094 (D.N.J.) Nov. 12, 2014 Hon. Faith S. Hochberg Brevibloc® (esmolol hydrochloride in sodium chloride solution) 6,310,094
6,528,540
Sucampo AG v. Dr. Reddy’s Labs., Inc., 14-7114 (D.N.J.) Nov. 12, 2014 Hon. Michael A. Shipp Amitiza® (lubiprostone capsules) 6,414,016
8,071,613
7,795,312
8,097,653
8,389,542
8,026,393
8,338,639
Mylan Pharms. Inc. v. Novartis AG, IPR2015-00265 (PTAB) Nov. 13, 2014 N/A Exelon® Patch (rivastigmine transdermal system or extended-release film) 6,316,023
Mylan Pharms. Inc. v. Novartis AG, IPR2015-00268 (PTAB) Nov. 13, 2014 N/A Exelon® Patch (rivastigmine transdermal system or extended-release film) 6,335,031
Baxter Healthcare Corp. v. Agila Specialties Private Ltd., 14-0190 (N.D.W.V.) Nov. 13, 2014 Hon. Irene M. Keeley Brevibloc® (esmolol hydrochloride in sodium chloride solution) 6,310,094
6,528,540
Purdue Pharma L.P. v. Watson Labs., Inc., 14-1410 (D. Del.) Nov. 14, 2014 Hon. Sue L. Robinson Butrans® (buprenorphine transdermal system) RE41,408
RE41,489
RE41,571
BioMarin Pharm. Inc. v. Dr. Reddy’s Labs., Inc., 14-7203 (D.N.J.) Nov. 17, 2014 Hon. Michael A. Shipp Kuvan® (sapropterin dihydrochloride tablets) 7,566,462
7,566,714
7,612,073
8,003,126
8,067,416
RE43,797
8,318,745
Teva Pharms. USA, Inc. v. Synthon Pharms. Inc., 14-1419 (D. Del.) Nov. 18, 2014 Hon. Gregory M. Sleet Copaxone® (glatiramer acetate for injection) 8,232,250
8,399,413
Teva Pharms. USA, Inc. v. Synthon Pharms. Inc., 14-0975 (D. Del.) Nov. 19, 2014 Hon. Catherine C. Eagles Copaxone® (glatiramer acetate for injection) 8,232,250
8,399,413
Par Pharm., Inc. v. GlaxoSmithKline LLC, 14-6627 (E.D. Pa.) Nov. 19, 2014 Hon. Nitza I. Quinones Alejandro Lamictal ODT® (lamotrigine tablets) 7,919,115
Endo Pharms. Solutions Inc. v. Paddock Labs., LLC, 14-1422 (D. Del.) Nov. 20, 2014 Hon. Sue L. Robinson Aveed® (testosterone undecanoate for injection) 7,718,640
8,338,395
Otsuka Pharm. Co., Ltd. v. Zydus Pharms. USA Inc., 14-7252 (D.N.J.) Nov. 20, 2014 Hon. Jerome B. Simandle Abilify® (aripiprazole tablets) 8,017,615
8,580,796
8,642,760
AstraZeneca AB v. Actavis Labs. FL, Inc., 14-7263 (D.N.J.) Nov. 20, 2014 Hon. Mary L. Cooper Nexium 24HR® (esomeprazole magnesium delayed-release capsules) 6,369,085
7,411,070
Supernus Pharms., Inc. v. Zydus Pharms. (USA) Inc., 14-7272 (D.N.J.) Nov. 21, 2014 Hon. Susan D. Wigenton Trokendi XR® (topiramate extended-release capsules) 8,298,576
8,298,580
8,663,683
Sanofi v. Sandoz Inc., 14-1434 (D. Del.) Nov. 24, 2014 Hon. Richard G. Andrews Multaq® (dronedarone hydrochloride tablets) 8,318,800
8,410,167
8,602,215
Fresenius Kabi USA, LLC v. Agila Specialties Private Ltd., 14-1438 (D. Del.) Nov. 26, 2014 Hon. Richard G. Andrews Diprivan® (propofol injectable) 8,476,010
Fresenius Kabi USA, LLC v. Agila Specialties Private Ltd., 14-0205 (N.D.W.V.) Nov. 26, 2014 Hon. Irene M. Keeley Diprivan® (propofol injectable) 8,476,010
Noven Therapeutics, LLC v. Prinston Pharm. Inc., 14-7400 (D.N.J.) Nov. 26, 2014 Hon. Faith S. Hochberg Brisdelle® (paroxetine mesylate capsule) 5,874,447
7,598,271
8,658,663
Otsuka Pharm. Co., Ltd. v. Alembic Pharms. Ltd., 14-7405 (D.N.J.) Nov. 26, 2014 Hon. Jerome B. Simandle Abilify® (aripiprazole tablets) 8,759,350
Bausch & Lomb Inc. v. Micro Labs USA, Inc., 14-7406 (D.N.J.) Nov. 26, 2014 Hon. Noel L. Hillman Bepreve® (bepotastine besilate ophthalmic solution) 8,784,789
Reckitt Benckiser Pharms. Inc. v. Teva Pharms. USA, Inc., 14-1451 (D. Del.) Dec. 2, 2014 Hon. Richard G. Andrews Suboxone® (buprenorphine hydrochloride / naloxone hydrochloride sublingual film) 8,475,832
8,017,150
8,603,514
Meda Pharms. Inc. v. Apotex Inc., 14-1453 (D. Del.) Dec. 2, 2014 Hon. Leonard P. Stark Dymista® (azelastine hydrochloride / fluticasone propionate nasal spray) 8,163,723
8,168,620
Novartis Pharms. Corp. v. Amneal Pharms., LLC, 14-7557 (D.N.J.) Dec. 3, 2014 Hon. Susan D. Wigenton Zometa® (zoledronic acid for injection) 8,324,189
Novartis Pharms. Corp. v. Par Sterile Products, LLC, 14-7558 (D.N.J.) Dec. 3, 2014 Hon. Susan D. Wigenton Zometa® / Reclast® (zoledronic acid for injection) 7,932,241
8,052,987
8,324,189
Allergan, Inc. v. Wilshire Pharms., Inc., 14-1461 (D. Del.) Dec. 4, 2014 Hon. Leonard P. Stark Lastacaft® (alcaftadine ophthalmic solution) 8,664,215
Eli Lilly and Co. v. Sandoz Inc., 14-2008 (S.D. Ind.) Dec. 5, 2014 Hon. Tanya Walton Pratt Alimta® (pemetrexed disodium for injection) 7,772,209
Fresenius Medical Care Holdings, Inc. v. Lotus Pharms. Co., Ltd., 14-14345 (D. Mass.) Dec. 5, 2014 Hon. Richard G. Stearns PhosLo® GelCaps (calcium acetate) 6,576,665
Fresenius Medical Care Holdings, Inc. v. Lotus Pharms. Co., Ltd., 14-7612 (D.N.J.) Dec. 5, 2014 Hon. Stanley R. Chesler PhosLo® GelCaps (calcium acetate) 6,576,665
Teva Women’s Health, Inc. v. Famy Care Ltd., 14-9637 (S.D.N.Y.) Dec. 5, 2014 Hon. Shira A. Scheindlin Quartette® (levonorgestrel / ethinyl estradiol and ethinyl estradiol tablets) 8,415,332
8,450,299
AstraZeneca AB v. Aurobindo Pharma Ltd., 14-1469 (D. Del.) Dec. 9, 2014 Hon. Gregory M. Sleet Onglyza® (saxagliptin hydrochloride tablets) RE44,186
Duke University v. Apotex, Inc., 14-1028 (M.D.N.C) Dec. 9, 2014 Hon. Catherine C. Eagles Latisse® (bimatoprost topical solution) 8,906,962
Eli Lilly and Co. v. Amneal Pharms. LLC, 14-2025 (S.D. Ind.) Dec. 10, 2014 Hon. Sarah Evans Barker Axiron® (testosterone metered transdermal solution) 8,435,449
8,419,307
8,177,409
8,807,861
Duke University v. Sandoz, Inc., 14-1034 (M.D.N.C.) Dec. 10, 2014 Hon. Catherine C. Eagles Latisse® (bimatoprost topical solution) 8,906,962
Lupin Ltd. v. ViiV Healthcare Co., IPR2015-00405 (PTAB) Dec. 10, 2014 N/A Lexiva® (fosamprenavir calcium) 6,436,989
Eli Lilly and Co. v. Amneal Pharms. LLC, 14-1474 (D. Del.) Dec. 11, 2014 Hon. Sue L. Robinson Axiron® (testosterone metered transdermal solution) 8,435,449
8,419,307
8,177,409
8,807,861
Jazz Pharms., Inc. v. Watson Labs., Inc., 14-7757 (D. Del.) Dec. 11, 2014 Hon. Esther Salas Xyrem® (sodium oxybate oral solution) 6,472,431
6,780,889
7,262,219
7,851,506
8,263,650
8,324,275
8,461,203
7,668,730
7,765,106
7,765,107
7,895,059
8,457,988
8,589,182
8,731,963
8,772,306
Apotex Inc. v. Merck and Co., Inc., IPR2015-00419 (PTAB) Dec. 11, 2014 N/A Emend® (fosaprepitant dimeglumine) 5,691,336
AstraZeneca Pharms. LP v. Teva Pharms. USA, Inc., 14-1478 (D. Del.) Dec. 12, 2014 Hon. Gregory M. Sleet Byetta® (exenatide injection) 6,858,576
6,872,700
6,956,026
7,297,761
6,902,744
7,521,423
7,741,269
Shire Development LLC v. Invagen Pharms., Inc., 14-7263 (E.D.N.Y.) Dec. 12, 2014 Hon. Brian M. Cogan Fosrenol® (lanthanum carbonate chewable tablets) 5,968,976
7,381,428
7,465,465
Boehringer Ingelheim Pharma Gmbh v. Teva Pharms. USA, Inc., 14-7811 (D.N.J.) Dec. 15, 2014 Hon. Mary L. Cooper Pradaxa® (dabigatran etexilate mesylate capsules) 6,087,380
Novartis AG v. Actavis, Inc., 14-1487 (D. Del.) Dec. 16, 2014 Hon. Leonard P. Stark Gilenya® (fingolimod hydrochloride capsules) 5,604,229
Novartis AG v. Actavis, Inc., 14-7849 (D.N.J.) Dec. 17, 2014 Hon. Madeline C. Arleo Gilenya® (fingolimod hydrochloride capsules) 5,604,229
AstraZeneca AB v. Actavis Labs. FL, Inc., 14-7870 (D.N.J.) Dec. 17, 2014 Hon. Joel A. Pisano Nexium® (esomeprazole magnesium delayed-release capsules) 5,714,504
6,369,085
7,411,070
8,466,175
Novartis Pharms. Corp. v. Par Pharm., Inc., 14-1494 (D. Del.) Dec. 18, 2014 Hon. Richard G. Andrews Afinitor® (everolimus tablets) 5,665,772
7,297,703
7,741,338
Ranbaxy Labs. Ltd v. Adamas Pharms., Inc., IPR2015-00410 (PTAB) Dec. 18, 2014 N/A Namenda XR® (memantine hydrochloride extended-release capsules) 8,362,085
Fresenius Kabi USA, LLC v. Claris Lifesciences Ltd., 14-1498 (D. Del.) Dec. 19, 2014 Hon. Richard G. Andrews Diprivan® (propofol injectable) 8,476,010
Cadence Pharms., Inc. v. Agila Specialties Private Ltd., Inc., 14-1499 (D. Del.) Dec. 19, 2014 Hon. Leonard P. Stark Ofirmev® (acetaminophen for injection) 6,028,222
6,992,218
Fresenius Kabi USA, LLC v. Claris Lifesciences Ltd., 14-7953 (D.N.J.) Dec. 19, 2014 Hon. Noel L. Hillman Diprivan® (propofol injectable) 8,476,010
Forest Labs., LLC v. Breckenridge Pharm., Inc., 14-1504 (D. Del.) Dec. 22, 2014 Hon. Sue L. Robinson Saphris® (asenapine maleate tablets) 5,763,476
8,022,228
7,741,358
Otsuka Pharm. Co., Ltd. v. Sciegen Pharms. Inc., 14-8077 (D.N.J.) Dec. 22, 2014 Hon. Jerome B. Simandle Abilify® (aripiprazole tablets) 8,017,615
8,580,796
8,642,760
Novartis Pharms. Corp. v. Roxane Labs., Inc., 14-1508 (D. Del.) Dec. 23, 2014 Hon. Richard G. Andrews Afinitor® (everolimus tablets) 5,665,772
7,297,703
7,741,338
Eisai Co., Ltd. v. Roxane Labs., Inc., 14-1511 (D. Del.) Dec. 23, 2014 Hon. Leonard P. Stark Banzel® (rufinamide oral suspension) 6,740,669
7,750,028
Iceutica Pty Ltd. v. Lupin Ltd., 14-1515 (D. Del.) Dec. 23, 2014 Hon. Sue L. Robinson Zorvolex® (diclofenac capsules) 8,679,544
Cadence Pharms., Inc. v. Agila Specialties Private Ltd., Inc., 14-8000 (D.N.J.) Dec. 23, 2014 Hon. Renee Marie Bumb Ofirmev® (acetaminophen for injection) 6,028,222
6,992,218
AstraZeneca AB v. Andrx Labs, 14-8030 (D.N.J.) Dec. 24, 2014 Hon. Joel A. Pisano Nexium 24HR® (esomeprazole magnesium delayed-release capsules) 6,369,085
7,411,070
Otsuka Pharm. Co., Ltd. v. Apotex Corp., 14-8074 (D.N.J.) Dec. 24, 2014 Hon. Jerome B. Simandle Abilify® (aripiprazole tablets) 8,017,615
8,580,796
8,642,760
8,759,350
Agila Specialties Inc. v. Cephalon, Inc., IPR2015-00503 (PTAB) Dec. 24, 2014 N/A Treanda® (bendamustine hydrochloride for infusion) 8,436,190
Novartis Pharms. Corp. v. Ranbaxy Inc., 14-1526 (D. Del.) Dec. 29, 2014 Hon. Leonard P. Stark Gleevec® (imatinib mesylate capsules) 6,894,051
RE43,932
Sanofi-Aventis U.S. LLC v. Accord Healthcare, Inc., 14-8079 (D.N.J.) Dec. 29, 2014 Hon. Michael A. Shipp Jevtana® Kit (cabazitaxel injection) 5,847,170
Sanofi-Aventis U.S. LLC v. BPI Labs, LLC, 14-8081 (D.N.J.) Dec. 29, 2014 Hon. Michael A. Shipp Jevtana® Kit (cabazitaxel injection) 5,847,170
Sanofi-Aventis U.S. LLC v. Fresenius Kabi USA, LLC, 14-8082 (D.N.J.) Dec. 29, 2014 Hon. Michael A. Shipp Jevtana® Kit (cabazitaxel injection) 5,847,170
Sanofi-Aventis U.S. LLC v. Fresenius Kabi USA, LLC, 14-1533 (D. Del.) Dec. 30, 2014 Hon. Leonard P. Stark Jevtana® Kit (cabazitaxel injection) 5,847,170
7,241,907
Sanofi-Aventis U.S. LLC v. BPI Labs, LLC, 14-3233 (M.D. Fla.) Dec. 30, 2014 Hon. Elizabeth A. Kovachevich Jevtana® Kit (cabazitaxel injection) 5,847,170
Reckitt Benckiser Pharms. Inc. v. Par Pharma., Inc., 14-1573 (D. Del.) Dec. 31, 2014 Hon. Richard G. Andrews Suboxone® (buprenorphine hydrochloride / naloxone hydrochloride sublingual film) 8,900,497
8,906,277
Reckitt Benckiser Pharms. Inc. v. Watson Labs., Inc., 14-1574 (D. Del.) Dec. 31, 2014 Hon. Richard G. Andrews Suboxone® (buprenorphine hydrochloride / naloxone hydrochloride sublingual film) 8,900,497
8,906,277
Apotex, Inc. v. Novartis AG, IPR2015-00518 (PTAB) Dec. 31, 2014 N/A Gilenya® (fingolimod capsules) 8,324,283

Back to Top